Infratil Limited

The Business

Infratil is a New Zealand-listed infrastructure holding company, externally managed by Morrison & Co, that owns stakes in nine assets across data centres, telecommunications, renewable energy, airports, and healthcare. CDC Data Centres (49.7% owned) dominates the portfolio at 43% of net asset value, operating sovereign-certified facilities across Australia and New Zealand. One NZ (formerly Vodafone NZ, 100% owned) is the second-largest holding at roughly 14% of NAV, generating steady cash as one of two national mobile operators. The remaining portfolio includes Longroad Energy (US renewables, 42%), Wellington Airport (66%), Qscan (Australian medical imaging), and several smaller positions. This is a conglomerate spanning four currencies and four industries.

Recent Performance

The stock has rallied sharply from around NZ$11.65 at FY26 year-end to current levels following CDC's announcement of a 555MW single-site contract with an investment-grade counterparty in May 2026. That contract was not embedded in prior guidance, providing genuine positive surprise. Proportionate EBITDAF (Infratil's share of earnings across all holdings before depreciation and finance costs) reached NZ$989 million in FY26. NAV per share rose to NZ$16.26, with CDC revaluations providing the bulk of the uplift. CDC's own EBITDAF of A$393 million in FY26 represented approximately 30% growth on the prior year, driven by new contracted capacity coming online. One NZ delivered flat revenue in a weak New Zealand economy but maintained its roughly 30% EBITDA margin, functioning as a reliable cash generator. Management divested Manawa Energy and RetireAustralia during FY26, realising over NZ$600 million in proceeds, though the RetireAustralia sale came below NAV.

Outlook

CDC's contracted capacity ramp is the dominant earnings driver. EBITDAF is guided to A$680-720 million in FY27, up from A$393 million in FY26, with a path exceeding A$1 billion by FY28. This is structural growth, not cyclical: over 1GW of capacity is contracted with investment-grade counterparties on average 27-year lease terms, meaning delivery depends on construction execution rather than new sales. On management's guided trajectory, proportionate EBITDAF grows at 21% in FY27 and 25% in FY28 from the FY26 base of NZ$989 million. Outside CDC, the outlook is flatter. One NZ generates stable cash in a weak New Zealand economy but offers minimal growth. Longroad Energy continues scaling its US renewables pipeline, though it remains a smaller contributor in NZD terms. The biggest source of forecast uncertainty is the pace at which CDC converts contracted capacity to operational capacity, which depends on construction timelines, power availability, and cooling infrastructure, all of which face supply-chain tightness in Australia.

Key Risks

CDC concentration is the primary vulnerability: 43% of portfolio value sits in a single asset class, and any material reversal in AI-driven data centre demand, whether through hyperscaler capital expenditure guidance cuts or contract deferrals, would have an outsized effect on the portfolio. The mitigation is significant given the contracted revenue base and take-or-pay provisions, but the concentration itself is a structural feature that does not disappear. Persistent elevated interest rates pose a second risk, compressing all long-duration infrastructure valuations regardless of growth profile. Australian 10-year yields at current levels are at elevated historical percentiles, and CPI and tight labour markets argue rates could persist longer than the market expects. CDC's CPI-linked lease escalators provide a partial hedge, but the discount rate effect on long-duration asset valuations applies across the entire portfolio. One NZ carries NZ$2.9 billion of goodwill on a telco with flat revenues in a struggling economy, creating impairment risk that, while limited in economic impact given the asset's ongoing cash distributions, could weigh on sentiment.

What to Watch

The thesis-defining event is CDC's FY27 interim EBITDAF update in October 2026, which will confirm whether the A$680-720 million full-year guidance is tracking. A beat would validate the contracted growth story and likely compress the holding company discount further.

• October 2026 CDC FY27 interim update — validates whether full-year EBITDAF guidance is on track; outperformance would be a material positive catalyst.
• Q3-Q4 2026 RBA rate decision — the direction of Australian rates affects all long-duration infrastructure valuations in the portfolio; a cut is a tailwind, a further hike a headwind.
• H1 2027 Qscan divestment — capital recycling into higher-return assets; execution at or above NAV would reinforce the capital allocation track record.

Company Description

Infratil is an infrastructure investment vehicle listed on both the ASX and NZX, externally managed by Morrison & Co under a long-term agreement. The portfolio spans nine holdings across four countries and currencies. CDC Data Centres (49.7% owned) is the centrepiece, operating sovereign-certified data centre campuses in Australia and New Zealand that house workloads for hyperscalers, the large cloud computing companies including Microsoft, Google, and Amazon. One NZ (100%) is New Zealand's second-largest mobile and broadband operator. Longroad Energy (42%) develops and operates utility-scale wind, solar, and storage projects across the United States with 5.4GW in operation. Wellington Airport (66%) is New Zealand's second-busiest airport. Qscan (100%) provides medical imaging services across Australia. Smaller holdings include Kao Data (UK data centres), RetireAustralia NZ healthcare, and listed stakes in Contact Energy (5.4%) and Gurīn Energy (Southeast Asian renewables). CDC and One NZ together represent roughly 57% of portfolio NAV.

Where the Growth Is

CDC Data Centres is the single growth engine that matters. It currently contributes 43% of NAV and will drive the substantial majority of NAV growth over the next three years. EBITDAF is growing at approximately 40% compound annual growth from A$393 million in FY26 toward a guided path exceeding A$1 billion by FY28, underpinned by over 1GW of contracted capacity. The 555MW contract announced in May 2026, a single site with a 30-year term and investment-grade counterparty, was not in prior guidance and illustrates the pace of demand acceleration. When fully deployed, CDC's annualised EBITDAF approaches A$2 billion. The contracted nature of this growth distinguishes it from speculative infrastructure development: the customers are signed, the revenue is committed, and execution on construction is the primary variable.

Competitive Position

CDC's competitive advantages are structural and difficult to replicate. The business holds "Certified Strategic" operator status across all its Australian and New Zealand facilities, a sovereignty credential required by government and critical infrastructure customers that new entrants cannot obtain quickly. Building this certification profile took over a decade. CDC's weighted average lease expiry of 27 years, with over 90% of counterparties rated investment grade, creates a revenue base more closely resembling a long-dated bond than a typical technology business. For context, the nearest listed comparable, NextDC, operates with 8-10 year lease terms. One NZ benefits from a duopoly market structure in New Zealand mobile, which supports pricing discipline, though the telco's competitive position is defensive rather than advantaged. The broader portfolio benefits from infrastructure characteristics, including regulated or contracted revenues and inflation-linked pricing, that provide earnings resilience through economic cycles.

Management & Capital Discipline

Morrison & Co has managed Infratil since inception, delivering a 17.9% since-inception internal rate of return over 30 years. Capital allocation has been disciplined: the team divested over NZ$600 million of assets in FY26 alone, including Manawa Energy at an 18% IRR and RetireAustralia, recycling proceeds into higher-growth opportunities. The early, contrarian positioning in data centres, beginning before the current AI-driven demand wave, has been well-timed. Morrison's incentive structure includes a 12% hurdle rate with a clawback mechanism that produced a negative incentive fee in FY26, meaning Morrison owed Infratil money because one asset underperformed. That alignment is stronger than most external management arrangements. One honest tension: Morrison's base management fee, charged at roughly 1% of assets, compounds as CDC scales. As the asset base grows toward NZ$30 billion and beyond, annual base fees could exceed NZ$200 million, a structural drag on returns that management has not publicly addressed.

Financial Position

Infratil carries 6.3 times leverage at the holding company level, elevated but consistent with infrastructure norms. It holds a BBB+ credit rating from S&P and maintains NZ$1.6 billion in undrawn credit facilities. The balance sheet complexity is real: NZ$2.9 billion of net debt at the parent level, plus NZ$1.2 billion in uncalled commitments representing capital pledged to CDC and Longroad that has not yet been drawn. Asset-level debt is mostly non-recourse, meaning a problem at one holding does not cascade to the parent. The company can service its obligations comfortably under the base case, though the combination of parent debt, uncalled commitments, and heavy CDC capital expenditure (A$3.8-4.2 billion guided for FY27) means financial flexibility is tighter than the investment-grade rating alone suggests. The dividend yield of approximately 1.6% at current prices sits well below infrastructure peers such as APA Group (6.5%) and Brookfield Infrastructure (4.5%), reflecting the holding company's conservative payout policy during CDC's build-out phase. Dividends are paid in NZD and are unfranked, reducing their after-tax value for Australian investors relative to franked alternatives.